MedPath
HSA Product

CYTARINE KABI SOLUTION FOR INJECTION OR INFUSION 100MG/ML

Product approved by Health Sciences Authority (SG)

Basic Information

CYTARINE KABI SOLUTION FOR INJECTION OR INFUSION 100MG/ML

INJECTION, SOLUTION

Regulatory Information

SIN17149P

December 18, 2024

Prescription Only

Therapeutic

INTRAVENOUS, SUBCUTANEOUS

May 23, 2025

June 3, 2025

Company Information

FRESENIUS KABI (SINGAPORE) PTE LTD

Active Ingredients

Cytarabine

Strength: 100 mg/ml

© Copyright 2025. All Rights Reserved by MedPath